Most patients over 65 don’t want life expectancy discussions

An online survey conducted in 2016 of a nationally representative group of 878 adults ages 65 and older found 59.4% did not want to talk about their life expectancy. Presented with a hypothetical situation that they were not immediately dying but had a shortened life expectancy, 59.9% indicated life expectancy discussions should not be initiated

Weeding out the ‘good’ and ‘bad’ of probiotics for our patients

Dr. Hecht is Professor of Medicine and Microbiology/Immunology and Chief, Gastroenterology and Nutrition at Loyola University Chicago.  She is the former President of the American Gastroenterological Association. In a guest commentary in cooperation between the American Gastroenterological Association and Healio, Dr. Hecht offers advice on how health care professionals can best discuss probiotics with their patients. See the article

Crohn’s & Colitis Congress 2019 in Las Vegas

Assessing which care guideline to follow can be a challenge for many providers who care for patients with inflammatory bowel diseases (IBD). To help IBD health care professionals navigate these complexities, the 2019 Crohn’s & Colitis Congress® will focus its opening session on How to Make Sense of Care Guidelines. See Dr. David Rubin from the University

No single test identifies reflux as the etiology for extra-esophageal symptoms.

It is well recognized that reflux can be causal in subgroups of patients with chest and ENT symptoms like asthma, cough, hoarseness, sore throat, sinusitis, and ear pain. However, the possibility of reflux as the cause for a variety of ENT symptoms is both overestimated and often abused. In fact, the cause of extraesophageal symptoms

PPI’s do not raise cardiovascular risk, study says

Proton pump inhibitor therapy is not connected to an increased risk of cardiovascular disease, according to a study published in Alimentary Pharmacology & Therapeutics. The FDA has discouraged using PPI’s with antiplatelet therapy clopidogrel because the drugs work with the same isoenzyme. “Inhibition of CYP2C19 by PPIs may reduce the bioavailability of the active metabolites of

Identifying IBS biomarkers will improve treatment

Identifying biomarkers and symptoms will allow doctors to shorten the length of time it takes to find an effective treatment for IBS patients, writes Dr. William Chey of Michigan Medicine. IBS is not a single disease but likely is several issues that have similar symptoms, Chey writes. Unfortunately, no reliable markers which distinguish the subtypes

Anesthesia Hand Off Mid-Surgery Increases Risk

Having an anesthesiologist hand off care and leave during the middle of a surgery was associated with worse outcomes for the patient on the operating table. Combined mortality, hospital readmission, and major complications within 30 days after the operation reached a rate of 44% when a handover between anesthesiologists occurred during surgery versus 29% when

Evidence for risks of PPI is weak

Experts say even though studies have linked proton pump inhibitor use to multiple health problems, the scientific evidence overall is weak, which should help providers reassure concerned patients and avoid unnecessary discontinuation of PPI use. The attention on PPI safety, however, does offer an opportunity for practitioners to discuss limiting use of the drugs because